Directory
>
Robert Waltermire
Robert Waltermire
Chief Pharmaceutical Development Officer | Madrigal Pharmaceuticals
Readington Township, New Jersey, United States
Robert Waltermire
Summary
Robert Waltermire is a seasoned executive in the pharmaceutical industry, currently serving as the Chief Pharmaceutical Development Officer at Madrigal Pharmaceuticals. With a PhD in Organic Chemistry from the University of Maryland, he has over three decades of experience in drug development, analytical chemistry, and technology transfer. His career spans multiple leadership roles at prominent companies, including Bristol Myers Squibb and Venatorx Pharmaceuticals, where he led teams in critical drug manufacturing processes. Robert's expertise encompasses a broad range of areas such as crystallization, GMP, and synthetic organic chemistry, making him a valuable asset in the pharmaceutical sector. He is known for his strategic vision and ability to guide complex projects from conception through to commercial supply. Beyond his technical skills, Robert is passionate about fostering innovation and driving organizational success in the ever-evolving pharmaceutical landscape.
Robert Waltermire
Work Experience
Chief Pharmaceutical Development Officer at
Madrigal Pharmaceuticals
August 2021 - Present
Senior Vice President CMC at
Venatorx Pharmaceuticals, Inc.
November 2020 - August 2021
Senior Vice President Product Development at
Palatin Technologies
February 2020 - November 2020
Head Chemical & Synthetic Development at
Bristol Myers Squibb
January 2016 - February 2020
Executive Director at
Bristol Myers Squibb
October 2001 - December 2015
Senior Director at
Dupont Pharmaceuticals
January 1991 - January 2001
Senior Director at
Dupont Merck Pharmaceutical Co
January 1991 - January 2001
Robert Waltermire
Education
University of Maryland, Phd
January 1986 - January 1988
January 1984 - January 1986
Franklin & Marshall College, Bachelor’s Degree
January 1980 - January 1984
Frequently Asked Questions about Robert Waltermire
What is Robert Waltermire email address?
Robert Waltermire's primary email address is ******@madrigalpharma.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Robert Waltermire work for?
Robert Waltermire is a Chief Pharmaceutical Development Officer at Madrigal Pharmaceuticals, a company specializing in Pharmaceutical & Medicine Manufacturing.
Where Robert Waltermire graduated from?
Robert Waltermire holds a degree in Organic Chemistry from University of Maryland.
How can I directly contact Robert Waltermire?
To contact Robert Waltermire directly, you can use the email address ******@madrigalpharma.com. Complete contact information is available upon registration with Muraena.
Who is Robert Waltermire?
Robert Waltermire is a seasoned executive in the pharmaceutical industry, currently serving as the Chief Pharmaceutical Development Officer at Madrigal Pharmaceuticals. With a PhD in Organic Chemistry from the University of Maryland, he has over three decades of experience in drug development, analytical chemistry, and technology transfer. His career spans multiple leadership roles at prominent companies, including Bristol Myers Squibb and Venatorx Pharmaceuticals, where he led teams in critical drug manufacturing processes. Robert's expertise encompasses a broad range of areas such as crystallization, GMP, and synthetic organic chemistry, making him a valuable asset in the pharmaceutical sector. He is known for his strategic vision and ability to guide complex projects from conception through to commercial supply. Beyond his technical skills, Robert is passionate about fostering innovation and driving organizational success in the ever-evolving pharmaceutical landscape.
Robert`s contact details
******@madrigalpharma.com
Colleagues
Executive Director FP&A
Executive Director GMP Quality Assurance
Executive Director, Trade and Specialty Distribution
Vice President, Medical Writing
Executive Director, Clinical Development
CIO
Strategic Consultant to CIO
Vice President, Pharmacovigilance and Medical Operations
SVP, Global Medical Affairs